{"disease":{"id":"reversible-cerebral-vasoconstriction-syndrome","name":"reversible cerebral vasoconstriction syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04463212","title":"Endothelial Dysfunction in Reversible Cerebral Vasoconstriction Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT03509701","title":"Reversible Cerebral Vasoconstriction Syndrome and Varicella Zoster Virus","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT03150524","title":"RCVS: The Rational Approach to Diagnosis and Treatment","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Johns Hopkins University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}